Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Mesothelioma | Research

Global, regional, and national burden of non-communicable diseases attributable to occupational asbestos exposure 1990–2019 and prediction to 2035: worsening or improving?

Authors: Xinlu Miao, Teng Yao, Chenxian Dong, Zuhai Chen, Wanting Wei, Zhengyang Shi, Tongtong Xu, Jianjiang Shao, Qiang Niu, Dongsheng Rui, Yunhua Hu, Yizhong Yan

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Understanding the burden associated with occupational asbestos exposure on a global and regional scale is necessary to implement coordinated prevention and control strategies. By the GBD Study 2019, we conducted a comprehensive assessment of the non-communicable diseases burden attributable to occupational asbestos exposure. In 2019, 239,330 deaths and 4,189,000 disability-adjusted life years (DALYs) worldwide due to occupational asbestos exposure occurred. 1990–2019, deaths and DALYs attributed to occupational asbestos exposure increased by 65.65% and 43.66%, respectively. Age-standardized mortality rate (ASMR) and age-standardized DALYs rate (ASDR) decreased, with the most rapid declines in high Socio-Demographic Index (SDI) regions, with average annual percent change (AAPC) of − 1.05(95%CI: −1.2, −0.89) and −1.53(95%CI: −1.71, −1.36), respectively. Lung cancer, mesothelioma and ovarian cancer were the top three contributors to the increase in deaths and DALYs, accounting for more than 96%. AAPCs of ASMR and ASDR were positively associated with SDI. Global deaths from occupational asbestos exposure were predicted to increase and ASMR to decrease by 2035, mostly in males. Due consideration should be given to the susceptibility of the elderly, the lag of asbestos onset, and the regional differences, and constantly improve the prevention and control measures of occupational asbestos exposure and related diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Izmerov NF. WHO and ILO Program on elimination of asbestos-related diseases. Med Tr Prom Ekol 2008(3):1–8. Izmerov NF. WHO and ILO Program on elimination of asbestos-related diseases. Med Tr Prom Ekol 2008(3):1–8.
2.
go back to reference Li N, Zhai Z, Zheng Y, Lin S, Deng Y, Xiang G, Yao J, Xiang D, Wang S, Yang P, et al. Association of 13 Occupational Carcinogens in patients with Cancer, individually and collectively, 1990–2017. JAMA Netw Open. 2021;4(2):e2037530.PubMedPubMedCentralCrossRef Li N, Zhai Z, Zheng Y, Lin S, Deng Y, Xiang G, Yao J, Xiang D, Wang S, Yang P, et al. Association of 13 Occupational Carcinogens in patients with Cancer, individually and collectively, 1990–2017. JAMA Netw Open. 2021;4(2):e2037530.PubMedPubMedCentralCrossRef
3.
go back to reference International Agency for Research on Cancer (IARC). IARC Monograph on evaluation of carcinogenic risks to Human, Arsenic, metals, Fibres and Dust: a review of human carcinogens. Volume 100. Lyon, France: IARC/WHO; 2012. pp. 219–309. International Agency for Research on Cancer (IARC). IARC Monograph on evaluation of carcinogenic risks to Human, Arsenic, metals, Fibres and Dust: a review of human carcinogens. Volume 100. Lyon, France: IARC/WHO; 2012. pp. 219–309.
4.
go back to reference Collaborators GOC. Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the global burden of Disease Study 2016. Occup Environ Med. 2020;77(3):151–9.CrossRef Collaborators GOC. Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the global burden of Disease Study 2016. Occup Environ Med. 2020;77(3):151–9.CrossRef
5.
go back to reference Chen T, Sun XM, Wu L. High time for Complete Ban on asbestos use in developing countries. JAMA Oncol. 2019;5(6):779–80.PubMedCrossRef Chen T, Sun XM, Wu L. High time for Complete Ban on asbestos use in developing countries. JAMA Oncol. 2019;5(6):779–80.PubMedCrossRef
6.
go back to reference Chen M, Wang H, Zhang J, Yu C, Liu W, Xu Y. Distribution of Asbestos Enterprises and asbestosis cases - China, 1997–2019. China CDC Wkly. 2020;2(18):305–9.PubMedPubMedCentralCrossRef Chen M, Wang H, Zhang J, Yu C, Liu W, Xu Y. Distribution of Asbestos Enterprises and asbestosis cases - China, 1997–2019. China CDC Wkly. 2020;2(18):305–9.PubMedPubMedCentralCrossRef
7.
go back to reference Damiran N, Frank A. Asbestos consumption in Mongolia: 1996–2014. Int J Env Res Pub Health. 2018;15(1):136.CrossRef Damiran N, Frank A. Asbestos consumption in Mongolia: 1996–2014. Int J Env Res Pub Health. 2018;15(1):136.CrossRef
8.
go back to reference Schuz J, Kovalevskiy E, Olsson A, Moissonnier M, Ostroumova E, Ferro G, Feletto E, Schonfeld SJ, Byrnes G, Tskhomariia I et al. Cancer mortality in chrysotile miners and millers, Russian Federation: main results (Asbest Chrysotile Cohort-Study). JNCI-J Natl Cancer I. 2024. Schuz J, Kovalevskiy E, Olsson A, Moissonnier M, Ostroumova E, Ferro G, Feletto E, Schonfeld SJ, Byrnes G, Tskhomariia I et al. Cancer mortality in chrysotile miners and millers, Russian Federation: main results (Asbest Chrysotile Cohort-Study). JNCI-J Natl Cancer I. 2024.
10.
go back to reference Yang M, Wang D, Gan S, Fan L, Cheng M, Yu L, Wang B, Li W, Ma J, Zhou M, et al. Increasing incidence of asbestosis worldwide, 1990–2017: results from the Global Burden of Disease study 2017. Thorax. 2020;75(9):798–800.PubMedCrossRef Yang M, Wang D, Gan S, Fan L, Cheng M, Yu L, Wang B, Li W, Ma J, Zhou M, et al. Increasing incidence of asbestosis worldwide, 1990–2017: results from the Global Burden of Disease study 2017. Thorax. 2020;75(9):798–800.PubMedCrossRef
11.
go back to reference Feder IS, Tischoff I, Theile A, Schmitz I, Merget R, Tannapfel A. The asbestos fibre burden in human lungs: new insights into the chrysotile debate. Eur Respir J. 2017;49(6):1602534.PubMedPubMedCentralCrossRef Feder IS, Tischoff I, Theile A, Schmitz I, Merget R, Tannapfel A. The asbestos fibre burden in human lungs: new insights into the chrysotile debate. Eur Respir J. 2017;49(6):1602534.PubMedPubMedCentralCrossRef
12.
go back to reference Nowak D, Schmalfeldt B, Tannapfel A, Mahner S. Asbestos exposure and ovarian Cancer - a Gynaecological Occupational Disease. Background, mandatory notification, practical Approach. Geburtsh Frauenheilk. 2021;81(5):555–61.PubMedPubMedCentralCrossRef Nowak D, Schmalfeldt B, Tannapfel A, Mahner S. Asbestos exposure and ovarian Cancer - a Gynaecological Occupational Disease. Background, mandatory notification, practical Approach. Geburtsh Frauenheilk. 2021;81(5):555–61.PubMedPubMedCentralCrossRef
13.
go back to reference Han Y, Zhang T, Chen H, Yang X. Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: results from the global burden of Disease Study 2019. Crit Rev Oncol Hemat. 2022;179:103821.CrossRef Han Y, Zhang T, Chen H, Yang X. Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: results from the global burden of Disease Study 2019. Crit Rev Oncol Hemat. 2022;179:103821.CrossRef
14.
go back to reference Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. B World Health Organ. 2011;89(10):716–24. 724A.CrossRef Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. B World Health Organ. 2011;89(10):716–24. 724A.CrossRef
15.
go back to reference Xu R, Barg FK, Emmett EA, Wiebe DJ, Hwang WT. Association between mesothelioma and non-occupational asbestos exposure: systematic review and meta-analysis. Environ Health-Glob. 2018;17(1):90. Xu R, Barg FK, Emmett EA, Wiebe DJ, Hwang WT. Association between mesothelioma and non-occupational asbestos exposure: systematic review and meta-analysis. Environ Health-Glob. 2018;17(1):90.
16.
go back to reference Collaborators GRF. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef Collaborators GRF. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef
17.
go back to reference Collaborators. GDAI: global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef Collaborators. GDAI: global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef
18.
19.
go back to reference Zhang R, He Y, Wei B, Lu Y, Zhang J, Zhang N, He R, Xue H, Zhu B. Nasopharyngeal Carcinoma Burden and its attributable risk factors in China: estimates and forecasts from 1990 to 2050. Int J Env Res Pub Health. 2023;20(4):2926.CrossRef Zhang R, He Y, Wei B, Lu Y, Zhang J, Zhang N, He R, Xue H, Zhu B. Nasopharyngeal Carcinoma Burden and its attributable risk factors in China: estimates and forecasts from 1990 to 2050. Int J Env Res Pub Health. 2023;20(4):2926.CrossRef
20.
go back to reference Yu J, Yang X, He W, Ye W. Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039. Int J Cancer. 2021;149(5):993–1001.PubMedCrossRef Yu J, Yang X, He W, Ye W. Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039. Int J Cancer. 2021;149(5):993–1001.PubMedCrossRef
21.
go back to reference Du Z, Chen W, Xia Q, Shi O, Chen Q. Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a bayesian age-period-cohort modeling study. Biomark Res. 2020;8:16.PubMedPubMedCentralCrossRef Du Z, Chen W, Xia Q, Shi O, Chen Q. Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a bayesian age-period-cohort modeling study. Biomark Res. 2020;8:16.PubMedPubMedCentralCrossRef
22.
go back to reference Knoll M, Furkel J, Debus J, Abdollahi A, Karch A, Stock C. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med Res Methodol. 2020;20(1):257.PubMedPubMedCentralCrossRef Knoll M, Furkel J, Debus J, Abdollahi A, Karch A, Stock C. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med Res Methodol. 2020;20(1):257.PubMedPubMedCentralCrossRef
23.
go back to reference Virta RL. Worldwide asbestos Supply and Consumption trends from 1900 through 2003. U.S. Geological Survey; 2006. Virta RL. Worldwide asbestos Supply and Consumption trends from 1900 through 2003. U.S. Geological Survey; 2006.
24.
go back to reference Rosato DV. Asbestos: its Industrial Applications. New York (N.Y.): Reinhold; 1959. Rosato DV. Asbestos: its Industrial Applications. New York (N.Y.): Reinhold; 1959.
25.
go back to reference Darnton A, Hodgson J, Benson P, Coggon D. Mortality from asbestosis and mesothelioma in Britain by birth cohort. Occup Med-Oxford. 2012;62(7):549–52.CrossRef Darnton A, Hodgson J, Benson P, Coggon D. Mortality from asbestosis and mesothelioma in Britain by birth cohort. Occup Med-Oxford. 2012;62(7):549–52.CrossRef
26.
go back to reference Barone-Adesi F, Ferrante D, Chellini E, Merler E, Pavone V, Silvestri S, Miligi L, Gorini G, Bressan V, Girardi P, et al. Role of asbestos clearance in explaining long-term risk of pleural and peritoneal cancer: a pooled analysis of cohort studies. Occup Environ Med. 2019;76(9):611–6.PubMedCrossRef Barone-Adesi F, Ferrante D, Chellini E, Merler E, Pavone V, Silvestri S, Miligi L, Gorini G, Bressan V, Girardi P, et al. Role of asbestos clearance in explaining long-term risk of pleural and peritoneal cancer: a pooled analysis of cohort studies. Occup Environ Med. 2019;76(9):611–6.PubMedCrossRef
27.
go back to reference Alfonso HS, Fritschi L, de Klerk NH, Olsen N, Sleith J, Musk AB. Effects of asbestos and smoking on gas diffusion in people exposed to crocidolite. Med J Austr. 2005;183(4):184–7.PubMedCrossRef Alfonso HS, Fritschi L, de Klerk NH, Olsen N, Sleith J, Musk AB. Effects of asbestos and smoking on gas diffusion in people exposed to crocidolite. Med J Austr. 2005;183(4):184–7.PubMedCrossRef
28.
go back to reference Thomas A, Chen Y, Yu T, Gill A, Prasad V. Distinctive clinical characteristics of malignant mesothelioma in young patients. Oncotarget. 2015;6(18):16766–73.PubMedPubMedCentralCrossRef Thomas A, Chen Y, Yu T, Gill A, Prasad V. Distinctive clinical characteristics of malignant mesothelioma in young patients. Oncotarget. 2015;6(18):16766–73.PubMedPubMedCentralCrossRef
29.
go back to reference Kanecki K, Kosinska I, Tyszko PZ, Nitsch-Osuch A, Gorynski P, Zielinski G. Asbestosis hospitalizations in Poland (2006–2016): results from the National Hospital Discharge Registry. Ann Agr Env Med. 2020;27(2):284–9.CrossRef Kanecki K, Kosinska I, Tyszko PZ, Nitsch-Osuch A, Gorynski P, Zielinski G. Asbestosis hospitalizations in Poland (2006–2016): results from the National Hospital Discharge Registry. Ann Agr Env Med. 2020;27(2):284–9.CrossRef
30.
go back to reference Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Scarselli A, Ferrante P, Bonafede M, Verardo M, Mirabelli D, Gennaro V, et al. The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure. Occup Environ Med. 2018;75(4):254–62.PubMedCrossRef Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Scarselli A, Ferrante P, Bonafede M, Verardo M, Mirabelli D, Gennaro V, et al. The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure. Occup Environ Med. 2018;75(4):254–62.PubMedCrossRef
31.
go back to reference Magnani C, Silvestri S, Angelini A, Ranucci A, Azzolina D, Cena T, Chellini E, Merler E, Pavone V, Miligi L, et al. Italian pool of asbestos workers cohorts: asbestos related mortality by industrial sector and cumulative exposure. Ann i Super Sanita. 2020;56(3):292–302. Magnani C, Silvestri S, Angelini A, Ranucci A, Azzolina D, Cena T, Chellini E, Merler E, Pavone V, Miligi L, et al. Italian pool of asbestos workers cohorts: asbestos related mortality by industrial sector and cumulative exposure. Ann i Super Sanita. 2020;56(3):292–302.
32.
go back to reference Peng WJ, Mi J, Jiang YH. Asbestos exposure and laryngeal cancer mortality. Laryngoscope. 2016;126(5):1169–74.PubMedCrossRef Peng WJ, Mi J, Jiang YH. Asbestos exposure and laryngeal cancer mortality. Laryngoscope. 2016;126(5):1169–74.PubMedCrossRef
33.
go back to reference Klebe S, Leigh J, Henderson DW, Nurminen M. Asbestos, smoking and Lung Cancer: an update. Int J Env Res Pub Health. 2019;17(1):258.CrossRef Klebe S, Leigh J, Henderson DW, Nurminen M. Asbestos, smoking and Lung Cancer: an update. Int J Env Res Pub Health. 2019;17(1):258.CrossRef
34.
go back to reference Boyle P LB. World Cancer Report 2008. Lyon, France: IARC Press, International Agency for Research on Cancer; 2008. Boyle P LB. World Cancer Report 2008. Lyon, France: IARC Press, International Agency for Research on Cancer; 2008.
35.
go back to reference Nelson HH, Kelsey KT. The molecular epidemiology of asbestos and tobacco in lung cancer. Oncogene. 2002;21(48):7284–8.PubMedCrossRef Nelson HH, Kelsey KT. The molecular epidemiology of asbestos and tobacco in lung cancer. Oncogene. 2002;21(48):7284–8.PubMedCrossRef
36.
go back to reference Nymark P, Wikman H, Hienonen-Kempas T, Anttila S. Molecular and genetic changes in asbestos-related lung cancer. Cancer Lett. 2008;265(1):1–15.PubMedCrossRef Nymark P, Wikman H, Hienonen-Kempas T, Anttila S. Molecular and genetic changes in asbestos-related lung cancer. Cancer Lett. 2008;265(1):1–15.PubMedCrossRef
37.
go back to reference Zhai Z, Ruan J, Zheng Y, Xiang D, Li N, Hu J, Shen J, Deng Y, Yao J, Zhao P, et al. Assessment of Global trends in the diagnosis of Mesothelioma from 1990 to 2017. JAMA Netw Open. 2021;4(8):e2120360.PubMedPubMedCentralCrossRef Zhai Z, Ruan J, Zheng Y, Xiang D, Li N, Hu J, Shen J, Deng Y, Yao J, Zhao P, et al. Assessment of Global trends in the diagnosis of Mesothelioma from 1990 to 2017. JAMA Netw Open. 2021;4(8):e2120360.PubMedPubMedCentralCrossRef
38.
go back to reference Collaborators GM. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet. 2017;390(10100):1084–150.CrossRef Collaborators GM. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet. 2017;390(10100):1084–150.CrossRef
40.
go back to reference Le GV, Takahashi K, Karjalainen A, Delgermaa V, Hoshuyama T, Miyamura Y, Furuya S, Higashi T, Pan G, Wagner G. National use of asbestos in relation to economic development. Environ Health Persp. 2010;118(1):116–9.CrossRef Le GV, Takahashi K, Karjalainen A, Delgermaa V, Hoshuyama T, Miyamura Y, Furuya S, Higashi T, Pan G, Wagner G. National use of asbestos in relation to economic development. Environ Health Persp. 2010;118(1):116–9.CrossRef
41.
go back to reference Albin M, Magnani C, Krstev S, Rapiti E, Shefer I. Asbestos and cancer: an overview of current trends in Europe. Environ Health Persp. 1999;107(Suppl 2):289–98.CrossRef Albin M, Magnani C, Krstev S, Rapiti E, Shefer I. Asbestos and cancer: an overview of current trends in Europe. Environ Health Persp. 1999;107(Suppl 2):289–98.CrossRef
42.
go back to reference Soeberg M, Vallance DA, Keena V, Takahashi K, Leigh J. Australia’s Ongoing legacy of asbestos: significant challenges remain even after the complete banning of asbestos almost fifteen years ago. Int J Env Res Pub Health. 2018;15(2):384.CrossRef Soeberg M, Vallance DA, Keena V, Takahashi K, Leigh J. Australia’s Ongoing legacy of asbestos: significant challenges remain even after the complete banning of asbestos almost fifteen years ago. Int J Env Res Pub Health. 2018;15(2):384.CrossRef
43.
go back to reference Park EK, Takahashi K, Hoshuyama T, Cheng TJ, Delgermaa V, Le GV, Sorahan T. Global magnitude of reported and unreported mesothelioma. Environ Health Persp. 2011;119(4):514–8.CrossRef Park EK, Takahashi K, Hoshuyama T, Cheng TJ, Delgermaa V, Le GV, Sorahan T. Global magnitude of reported and unreported mesothelioma. Environ Health Persp. 2011;119(4):514–8.CrossRef
44.
go back to reference Carel R, Olsson AC, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabianova E, Cassidy A, Mates D, Bencko V, et al. Occupational exposure to asbestos and man-made vitreous fibres and risk of lung cancer: a multicentre case-control study in Europe. Occup Environ Med. 2007;64(8):502–8.PubMedCrossRef Carel R, Olsson AC, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabianova E, Cassidy A, Mates D, Bencko V, et al. Occupational exposure to asbestos and man-made vitreous fibres and risk of lung cancer: a multicentre case-control study in Europe. Occup Environ Med. 2007;64(8):502–8.PubMedCrossRef
Metadata
Title
Global, regional, and national burden of non-communicable diseases attributable to occupational asbestos exposure 1990–2019 and prediction to 2035: worsening or improving?
Authors
Xinlu Miao
Teng Yao
Chenxian Dong
Zuhai Chen
Wanting Wei
Zhengyang Shi
Tongtong Xu
Jianjiang Shao
Qiang Niu
Dongsheng Rui
Yunhua Hu
Yizhong Yan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18099-4

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue